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Rat-to-Elephant-
to-Human 
Transmission of 
Cowpox Virus
To the Editor: Despite the eradi-
cation of smallpox in the past cen-
tury, other orthopoxviruses, such as 
monkeypox virus, vaccinia virus in 
Brazil, and cowpox virus (CPXV) in 
Europe (1), still infect humans. CPXV 
has been restricted to the Old World 
with wild rodents as its natural reser-
voir (2,3). Human CPXV infections 
are commonly described in relation to 
contact with diseased domestic cats, 
rarely directly from rats (2,4). Human 
infections usually remain localized 
and self-limiting but can become fa-
tal in immunosuppressed patients (5). 
CPXV infections in captive exotic ani-
mals have been reported to be trans-
mitted by rodents (2,6).
In February 2007, a circus el-
ephant (Elephas maximus) in north-
ern Germany exhibited  disseminated 
ulcerative lesions of the skin and 
mucosal membranes (Figure, panel 
A) caused by CPXV infection; the 
elephant was euthanized after treat-
ment attempts failed. Electron mi-
crographs of negative-stained biopsy 
specimens of tongue lesions showed 
orthopoxvirus particles. The pres-
ence of orthopoxvirus after routine 
virus isolation in Hep2 cells was 
conﬁ   rmed in direct immunoﬂ  uores-
cence assay with orthopox-speciﬁ  c 
antibodies. The morphologic feature 
of hemorrhagic pocks on the chorioal-
lantoic membrane (CAM) of infected 
embryonated hen’s eggs indicated 
CPXV. This ﬁ   nding was conﬁ  rmed 
by sequence analysis of the complete 
hemagglutinin (HA) open reading 
frame (ORF), which showed 99% ho-
mology of 921 bp to CPXV isolated 
in 1984 from an elephant in Hamburg, 
Germany (Figure, panel B). A serum 
sample was drawn from the elephant 
2 weeks before euthanasia. An indi-
rect ﬂ  uorescent antibody test (IFAT) 
detected immunoglobulin (Ig) G anti-
bodies against the new corresponding 
elephant virus isolate (termed CPXV 
GuWi) with a titer of 1,260. According 
to the owner, the >40-year-old female 
elephant had never been vaccinated 
with vaccinia virus.
Eight days after the elephant’s 
death,  a circumscribed lesion devel-
oped on the back of the right hand 
of a 19-year-old immunocompetent, 
healthy, unvaccinated animal keeper. 
CPXV was isolated from lesion ﬂ  uid 
and was found to be homologous by 
using the HA ORF to CPXV GuWi. 
A convalescent-phase serum sample 
from the keeper taken 3 weeks later 
showed a signiﬁ  cant increase in IgM 
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Figure. Route of cowpox virus (CPXV) transmission and phylogenetic analysis of 
orthopoxviruses. A) Disseminated ulcerative lesions of the skin around the eye of the 
circus elephant. Although transmission of CPXV has been conﬁ  rmed from cats and cows 
to humans (1,2), transmission from rodents, commonly mice, to cats and cows is suspected 
but still unproven (3). Rats have been conﬁ  rmed as vectors for CPXV transmission to 
monkeys and humans (4,7). A complete chain of CPXV infection is veriﬁ  ed from rat to 
elephant and from elephant to human. B) Phylogenetic tree of nucleotide sequences of 
the complete hemagglutinin open reading frame (921 bp) from CPXV isolates from the 
elephant and rat (CPXV GuWi), and additional poxviruses available in GenBank: VARV 
(variola major virus, strain Bangladesh-1975; L22579), CMLV (camelpox virus M-96, 
Kazakhstan; AF438165.1), ECTV (ectromelia virus, strain Moscow; AF012825.2), CPXV 
HH (cowpox virus cowHA68, Hamburg; AY902298.2), MPXV (monkeypox virus, strain 
Zaire-96-I-16; AF380138.1), and VACV (vaccinia virus WR; AY243312). In addition, the 
complete sequence of the hemagglutinin gene obtained from a different human CPXV 
case (CPXV #2) found in that area is shown. Nucleotide sequences were aligned and 
analyzed by using the BioEdit software package (www.mbio.ncsu.edu/BioEdit/bioedit.htm). 
A multiple alignment was analyzed with the neighbor-joining method. The branch length is 
proportional to evolutionary distance (scale bar).LETTERS
(from 40 to 2,560), IgG (from 20 to 
10,240), and neutralizing antibody 
(from <5 to 80) titers.
Further simultaneous investiga-
tions were undertaken to determine 
the source of infection. Because no fe-
lids were kept on the circus premises, 
the focus centered on wild rodents that 
had propagated and infested the area 
because of the mild winter. Six days 
after the elephant’s death, 4 rats (Rat-
tus norvegicus) were caught and tested 
for orthopoxvirus antibodies. Although 
none of the rats had epidermal lesions 
or other pathologic changes indicative 
of a poxvirus infection, all were tested 
by IFAT and found to be serologically 
positive (IgG titers 40, 320, 2,560, and 
>10,240; IgM titers <5, <5, 160, and 
2,560), indicating a recent infection in 
at least 2 animals. CPXV-typical pock 
morphologic features on the CAM 
could be visualized after homogenized 
liver and spleen of the animal with the 
highest titer was passaged 3 times. In-
fected CAM and original organ tissues 
(liver and spleen) showed CPXV by 
PCR and subsequent sequencing. The 
corresponding HA ORF displayed 
perfect homology to the viruses iso-
lated from the elephant and the animal 
keeper.
We report CPXV infection in hu-
mans transmitted from an elephant, 
with rats as a probable source of the 
elephant’s infection (Figure, panel 
A). Although the animal keeper was 
infected by direct contact with the el-
ephant, the exact transmission route 
from rat to elephant remains unclear. 
Nevertheless, rats have proven to be 
a natural reservoir for CPXV (4,7), 
and infections persisting for >3 weeks 
were shown for other rodents (8). No 
data about CPXV prevalence in rats 
are available, and no data for CPXV 
isolates from rats have been published 
in Germany. Therefore, further studies 
on rats as CPXV reservoir are need-
ed to estimate the potential risk for 
infection among humans and exotic 
animals. Zoo and circus animals, es-
pecially elephants, seem to be highly 
susceptible to generalized CPXV in-
fections. Although modiﬁ  ed vaccinia 
virus Ankara was authorized in Ger-
many to be used in vaccinating exotic 
animals (9), this case highlights the 
need for increased efforts toward gen-
eral vaccination of potentially suscep-
tible exotic animals in Europe.
The sequence identity of the HA 
ORFs also demonstrates a low mu-
tation rate of CPXV after it crosses 
species barriers. As the Figure, panel 
B, infers, there is a phylogenetic dif-
ference between CPCV GuWi and 
CPXV from a human patient living in 
the same geographic area (CPXV #2), 
which indicates the cocirculation of 
>1 CPXV variant (9,10). Considering 
the extremely high virus load in in-
fected animals, the broad host range of 
CPXV, and the abandoned vaccination 
against smallpox, this case emphasiz-
es the risk among humans of acquiring 
CPXV infection (6). It also highlights 
the need for increased awareness re-
garding clinical features of orthopox-
virus infections and the importance of 
developing new antiviral drugs against 
orthopoxviruses.
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